Rhabdomyolysis and severe muscle weakness secondary to colistin therapy

Renal Failure

Volumn 34, Issue 7, 2012, Pages 926-929

  Özkan, Gülsüm ^a   Ulusoy, Şükrü ^a   Gazioǧlu, Sibel ^a   Cansiz, Muammer ^a   Kaynar, Kübra ^a   Ari, Derya ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

acute renal failure; colistin; muscle weakness; rhabdomyolysis

Indexed keywords

BICARBONATE; COLISTIN; CREATINE KINASE; CREATININE; CYCLOPHOSPHAMIDE; HEMOGLOBIN; METHYLPREDNISOLONE; MYOGLOBIN; NEOMYCIN; PHOSPHORUS; PIPERACILLIN PLUS TAZOBACTAM; POTASSIUM; URIC ACID;

ACINETOBACTER; ADULT; ANURIA; ARTERIAL PRESSURE; ARTICLE; BLOOD GAS; BREATHING RATE; CARBON DIOXIDE TENSION; CASE REPORT; CREATININE BLOOD LEVEL; DISORIENTATION; ELECTROMYOGRAM; ELECTROMYOGRAPHY; EMERGENCY WARD; FATIGUE; FEMALE; FEVER; HANTAVIRUS; HANTAVIRUS INFECTION; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HEMOPTYSIS; HUMAN; INTUBATION; KIDNEY FUNCTION; LABORATORY TEST; LEUKOCYTE; MICTURITION; MUSCLE STRENGTH; MUSCLE WEAKNESS; NEPHROTOXICITY; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; OXYGEN TENSION; PH; PHOSPHATE BLOOD LEVEL; PHYSICAL EXAMINATION; PNEUMONIA; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PULSE RATE; QUADRIPLEGIA; RATING SCALE; RHABDOMYOLYSIS; SINGLE DRUG DOSE; TACHYPNEA; TENDON REFLEX; THORAX RADIOGRAPHY; THROMBOCYTE; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL; URINALYSIS;

ANTI-BACTERIAL AGENTS; COLISTIN; FEMALE; HUMANS; MIDDLE AGED; PARESIS; RHABDOMYOLYSIS;

EID: 84863874810     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.684513     Document Type: Article

References (9)

1. Holt SG, Moore KP. Pathogenesis and treatment of renal dysfunction in rhabdomyolysis. Intensive Care Med. 2001;27:803-811. (Pubitemid 32480507)
2. Holt S, Moore K. Pathogenesis of renal failure in rhabdomyolysis: The role of myoglobin. Exp Nephrol. 2000;8:72-76. (Pubitemid 30161093)
3. Falagas ME, Kasiakou SK. Toxicity of polymyxins: A systematic review of the evidence from old and recent studies. Crit Care. 2006;10:27.
4. Wareham DW, Bean DC, Khanna P, et al. Bloodstream infection due to Acinetobacter spp.: Epidemiology, risk factors and impact of multi-drug resistance. Eur J Clin Microbiol Infect Dis. 2008;27:607-612.
5. Berg JR, Spilker CM, Lewis SA. Modulation of polymyxin B effects on mammalian urinary bladder. Am J Physiol. 1998;275:204-215.
6. Evagelopoulou P, Katsaros A, Myrianthefs P, et al. Colistin and rhabdomyolysis: A causative agent or an innocent bystander? Intensive Care Med. 2007;33:556-557. (Pubitemid 46333846)
7. Cervellin G, Comelli I, Lippi G. Rhabdomyolysis: Historical background, clinical, diagnostic and therapeutic features. Clin Chem Lab Med. 2010;48:749-756.
8. Kim J, Lee KH, Yoo S, Pai H. Clinical characteristics and risk factors of colistin-induced nephrotoxicity. Int J Antimicrob Agents. 2009;34:434-438.
9. Moore KP, Holt SG, Patel RP, et al. A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J Biol Chem. 1998;273:31731-31737. (Pubitemid 29177103)